Hepatocellular Carcinoma-The Influence of Immunoanatomy and the Role of Immunotherapy.

ABSTRACT: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related morbidity and mortality worldwide. Most patients are diagnosed with advanced disease, limiting their options for treatment. While current treatments are adequate for lower staged disease, available systemic treatments are limited, with marginal benefit at best. Chimeric antigen receptor (CAR) T cell therapy, effective in treating liquid tumors such as B-cell lymphoma, presents a potentially promising treatment option for advanced HCC. However, new challenges specific to solid tumors, such as tumor immunoanatomy or the immune cell presence and position anatomically and the tumor microenvironment, need to be defined and overcome. Immunotherapy currently in use must be re-engineered and re-envisioned to treat HCC with the hop

SUBMITTER: Patel K 

PROVIDER: S-EPMC7555667 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature